TSUMOYLE Trademark

Trademark Overview


On Tuesday, September 18, 2018, a trademark application was filed for TSUMOYLE with the United States Patent and Trademark Office. The USPTO has given the TSUMOYLE trademark a serial number of 79246187. The federal status of this trademark filing is REGISTERED as of Tuesday, November 19, 2019. This trademark is owned by Clinuvel (UK) Ltd. The TSUMOYLE trademark is filed in the Cosmetics & Cleaning Products and Pharmaceutical Products categories with the following description:

Non-medicated skin care preparations; cosmetic preparations for skin care; cosmetic preparations for skin care, based on analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; cosmetic oils; cosmetic skin creams; skin care creams, lotions and oils for cosmetic purposes; wrinkle removing skin care preparations; cosmetic sunscreen preparations; waterproof sunscreen; sunscreen preparations; sunscreen creams and lotions; cosmetics for protecting the skin from sunburn; sunblock lotions; cosmetic sun barriers; sun creams; cosmetic preparations for protecting the skin from the sun's rays; sun care lotions; cosmetic compounds for skin care after exposure to the sun's rays; after-sun milks, creams, lotions and moisturizers; sun skin bronzers; sun-tanning preparations; cosmetics for tanning the skin including preparations for tanning without sunlight, containing analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; cosmetics for tanning the skin...

Pharmaceuticals for use in dermatology, for skin care, for the treatment of skin and skin relating conditions and disorders, for the treatment of damaged skin and tissue, for the treatment of sunburn, for the protection of the dermis and epidermis, for skin wounds; pharmaceuticals for skin care and for the treatment of skin and skin relating conditions and disorders based on analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; pharmaceutical drugs for use in dermatology, for skin care, for the treatment of skin and skin relating conditions and disorders, for the treatment of damaged skin and tissue, for the treatment of sunburn, for the protection of the dermis and epidermis, for skin wounds; pharmaceutical drugs for skin care and for the treatment of skin and skin relating conditions and disorders based on analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; pharmaceutical preparations for use in dermatology, for skin care, for the...
tsumoyle

General Information


Serial Number79246187
Word MarkTSUMOYLE
Filing DateTuesday, September 18, 2018
Status700 - REGISTERED
Status DateTuesday, November 19, 2019
Registration Number5911072
Registration DateTuesday, November 19, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 3, 2019

Trademark Statements


Goods and ServicesNon-medicated skin care preparations; cosmetic preparations for skin care; cosmetic preparations for skin care, based on analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; cosmetic oils; cosmetic skin creams; skin care creams, lotions and oils for cosmetic purposes; wrinkle removing skin care preparations; cosmetic sunscreen preparations; waterproof sunscreen; sunscreen preparations; sunscreen creams and lotions; cosmetics for protecting the skin from sunburn; sunblock lotions; cosmetic sun barriers; sun creams; cosmetic preparations for protecting the skin from the sun's rays; sun care lotions; cosmetic compounds for skin care after exposure to the sun's rays; after-sun milks, creams, lotions and moisturizers; sun skin bronzers; sun-tanning preparations; cosmetics for tanning the skin including preparations for tanning without sunlight, containing analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; cosmetics for tanning the skin including preparations for tanning without sunlight, not containing analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; cosmetic self-tanning preparations; self -tanning creams and lotions for cosmetic purposes; suntan creams, lotions, oils and gels; non-medicated skin rejuvenation preparations, namely, creams, lotions, moisturizers, gels, balms, serums, oils, toners, cleaners and peels; non-medicated skin rejuvenation products, namely, creams, lotions, moisturizers, gels, balms, serums, oils, toners, cleaners and peels with and without analogues of alpha-melanocyte stimulating hormone (alpha-MSH); non-medicated antiaging skincare preparations; antiaging creams, lotions, moisturizers, gels, balms and serums; skin cleansing creams, lotions, milks, foams, gels and masks for cosmetic purposes
Goods and ServicesPharmaceuticals for use in dermatology, for skin care, for the treatment of skin and skin relating conditions and disorders, for the treatment of damaged skin and tissue, for the treatment of sunburn, for the protection of the dermis and epidermis, for skin wounds; pharmaceuticals for skin care and for the treatment of skin and skin relating conditions and disorders based on analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; pharmaceutical drugs for use in dermatology, for skin care, for the treatment of skin and skin relating conditions and disorders, for the treatment of damaged skin and tissue, for the treatment of sunburn, for the protection of the dermis and epidermis, for skin wounds; pharmaceutical drugs for skin care and for the treatment of skin and skin relating conditions and disorders based on analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; pharmaceutical preparations for use in dermatology, for skin care, for the treatment of skin and skin relating conditions and disorders, for the treatment of damaged skin and tissue, for the treatment of sunburn, for the protection of the dermis and epidermis, for skin wounds; pharmaceutical preparations for skin care and for the treatment of skin and skin relating conditions and disorders based on analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; sun tanning preparations for pharmaceutical purposes, containing analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; sun tanning preparations for pharmaceutical purposes, not containing analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; medicated dermatological preparations; dermatological pharmaceutical substances; dermatological pharmaceutical products; medicinal creams for the protection of the skin; skin care creams for medical use; skin care preparations for medical use; medicated skin creams and lotions; medicated creams for application after exposure to the sun; pharmaceutical skin lotions; preparations for cleansing the skin for medical use; chemical and biological preparations, substances, reagents and compounds for use in dermatology, for skin care, for the treatment of skin and skin relating conditions and disorders, for the treatment of damaged skin and tissue, for the treatment of sunburn, for the protection of the dermis and epidermis, for skin wounds, all used for the delivery and storage of pharmaceuticals containing analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide
Translation of Words in MarkThe wording "TSUMOYLE" has no meaning in a foreign language.

Classification Information


International Class003 - Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring and abrasive preparations; soaps; perfumery, essential oils, cosmetics, hair lotions; dentifrices.
US Class Codes001, 004, 006, 050, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 26, 2018
Primary Code003
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 26, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameClinuvel (UK) Ltd
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressLondon EC1M 7AD
GB

Party NameClinuvel (UK) Ltd
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLondon EC1M 7AD
GB

Party NameClinuvel (UK) Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLondon EC1M 7AD
GB

Trademark Events


Event DateEvent Description
Friday, March 27, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, March 11, 2020FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, March 11, 2020FINAL DISPOSITION PROCESSED
Wednesday, February 19, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, November 19, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, October 9, 2019CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Wednesday, October 9, 2019ASSIGNED TO PETITION STAFF
Tuesday, September 10, 2019TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, September 3, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 3, 2019PUBLISHED FOR OPPOSITION
Friday, August 30, 2019NOTIFICATION PROCESSED BY IB
Wednesday, August 14, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, August 14, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, August 14, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, July 29, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, July 20, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, July 20, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 16, 2019ASSIGNED TO LIE
Thursday, July 11, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, February 2, 2019REFUSAL PROCESSED BY IB
Wednesday, January 16, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, January 16, 2019REFUSAL PROCESSED BY MPU
Saturday, January 5, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, January 4, 2019NON-FINAL ACTION WRITTEN
Friday, December 28, 2018ASSIGNED TO EXAMINER
Friday, November 30, 2018APPLICATION FILING RECEIPT MAILED
Monday, November 26, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, November 22, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB